- Issuer ticker
-
FENC
- Reported as of
-
31 Jan 2025
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
03 Feb 2025, 17:48:29 UTC
Filing notes and source
Key filing fact
Robert Andrade filed Form 4 for FENNEC PHARMACEUTICALS INC. (FENC) on 03 Feb 2025.
Key facts
- This page summarizes Robert Andrade's Form 4 filing for FENNEC PHARMACEUTICALS INC. (FENC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2025, 17:48.
Change
- Previous filing in this sequence was filed on 03 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FENC
transaction
Common shares
Award
- Transaction value
- $0
- Shares
- +1,042
- Change %
- +0.8%
- Price
-
$0.000000
- Shares after
- 130,507
- Date
- 31 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote